Clearpoint Neuro
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $12,075 | $10,880 | $12,128 | $10,410 |
Gross Profit | 7,059 | 6,917 | 7,549 | 6,404 |
EBITDA | -4,710 | -8,870 | -7,049 | -6,228 |
EBIT | -6,332 | -10,244 | -8,162 | -7,079 |
Net Income | -7,460 | -11,337 | -9,552 | -7,786 |
Net Change In Cash | 12,075 | 10,880 | 12,128 | 10,410 |
Free Cash Flow | -5,249 | -7,229 | -8,612 | -12,129 |
Cash | 46,184 | 29,363 | 35,593 | 45,923 |
Basic Shares | 30,983 | 29,858 | 29,546 | 28,315 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $36,971 | $31,390 | $23,955 | $20,551 |
Gross Profit | 22,692 | 19,122 | 13,614 | 13,531 |
EBITDA | -20,860 | -17,011 | -20,632 | -15,577 |
EBIT | -23,097 | -18,914 | -22,089 | -16,354 |
Net Income | -25,540 | -18,914 | -22,089 | -16,435 |
Net Change In Cash | 36,971 | 31,390 | 23,955 | 20,551 |
Cost of Revenue | -26,494 | |||
Free Cash Flow | -24,447 | -9,225 | -14,437 | -16,420 |
Cash | 45,923 | 20,104 | 23,140 | 27,615 |
Basic Shares | 28,315 | 27,027 | 24,605 | 24,181 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.24 |
2026-06-30 | -$0.38 |
2026-03-31 | -$0.32 |
2025-12-31 | -$0.27 |